Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007–13) and prospective (2014–18) MIDAS sales data analysis

BACKGROUND: Health Canada has defined rare diseases as life-threatening, seriously debilitating, or serious chronic conditions affecting a very small number of patients (~1 in 2,000 persons). An estimated 9 % of Canadians suffer from a rare disease. Drugs treating rare diseases (DRDs) are also known...

Descripción completa

Detalles Bibliográficos
Autores principales: Divino, Victoria, DeKoven, Mitch, Kleinrock, Michael, Wade, Rolin L., Kim, Tony, Kaura, Satyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875716/
https://www.ncbi.nlm.nih.gov/pubmed/27207271
http://dx.doi.org/10.1186/s13023-016-0450-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875716/
https://www.ncbi.nlm.nih.gov/pubmed/27207271
http://dx.doi.org/10.1186/s13023-016-0450-y

Ejemplares similares